Health-related quality of life in Chinese children with immune thrombocytopaenia: a multicentre study - Scorecard - MDSpire

Health-related quality of life in Chinese children with immune thrombocytopaenia: a multicentre study

  • By

  • Shuxian Huang

  • Min Chen

  • Hui Zhang

  • Yongzhi Zheng

  • Sihan Huang

  • Zhiyuan Chen

  • Jinhong Luo

  • Liyun Xiao

  • Jinhua Chu

  • Biyun Guo

  • Yan Dai

  • Yuantao Huang

  • Shuhong Shen

  • Haixia Zhou

  • Kaizhi Weng

  • April 1, 2026

  • 0 min

Share

Clinical Scorecard: Assessment of Health-Related Quality of Life in Chinese Pediatric Patients with Immune Thrombocytopaenia: A Multicenter Investigation

At a Glance

CategoryDetail
ConditionImmune Thrombocytopaenia (ITP)
Key MechanismsAccelerated platelet destruction and impaired platelet production leading to isolated thrombocytopaenia.
Target PopulationChinese children with newly diagnosed ITP
Care SettingMulticenter study across nine tertiary hospitals

Key Highlights

  • Significant parent-child discordance in HRQoL scores (mean difference 20.06 points at diagnosis, p<0.001).
  • Excellent scale reliability (parent α=0.944, child α=0.910).
  • Transient HRQoL reductions following bone marrow aspiration and glucocorticoid therapy.
  • No association between baseline platelet counts and HRQoL.
  • Age-specific patterns in HRQoL reporting between parents and children.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis established according to the American Society of Hematology guidelines.

Management

  • Adoption of the Kids’ ITP Tools scale in clinical practice to guide patient-centred, symptom-based care.

Monitoring & Follow-up

  • Longitudinal tracking of HRQoL outcomes at key clinical timepoints.

Risks

  • Potential for chronic ITP in 20%-30% of cases, complicating prognosis prediction.

Patient & Prescribing Data

Chinese pediatric patients with newly diagnosed ITP.

35%-50% of children report persistent fatigue even after platelet-count recovery.

Clinical Best Practices

  • Implement culturally informed family-centred psychosocial interventions.
  • Utilize disease-specific HRQoL tools for better assessment of patient needs.

Related Resources & Content

Original Source(s)

Related Content